返回
TYK Medicines, Inc（02410.HK）价格
02410.HK 股价走势图
TYK MEDICINES-B (02410.HK)
TYK Medicines, Inc
HK$13.56
-2.72%
$-0.37
休市： Jan 16, 16:00:00 HKT
关键数据
前收盘价
$13.72
开盘价
$13.94
当日区间
$13.4 - $13.94
52周范围
$12.1 - $46.1
交易量
2.0M
平均成交量
3.3M
每股收益（TTM）
-0.84
股息收益率
--
市值
$5.0B
什么是 TYK MEDICINES-B？
TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai and currently employs 163 full-time employees. The company went IPO on 2024-08-20. The firm is primarily focused on small molecule drug development, and its main products include TY-9591, TY-302 and TY-2136. TY-9591 is a third-generation EGFR-TKI with antitumor effects on EGFR mutations. TY-302 is a potent, selective oral CDK4/6 inhibitor developed for the treatment of advanced solid tumors, including breast cancer and prostate cancer. TY-2136b is an internally developed, oral ROS1/NTRK inhibitor for the treatment of solid tumors.
